VERTEX PHARMACEUTICALS INC / MA Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Vertex Pharmaceuticals Inc / Ma Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $154M, a 29.3% increase year-over-year.
  • Vertex Pharmaceuticals Inc / Ma Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $686M, a 40.3% increase year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Share-based Payment Arrangement, Expense for 2023 was $581M, a 18.3% increase from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Share-based Payment Arrangement, Expense for 2022 was $491M, a 11.3% increase from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Share-based Payment Arrangement, Expense for 2021 was $441M, a 2.77% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $581M +$89.9M +18.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $491M +$49.9M +11.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $441M +$11.9M +2.77% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $430M +$69M +19.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $361M +$35.5M +10.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $325M +$31.8M +10.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $293M +$52.6M +21.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $241M +$9.6M +4.16% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 $231M +$53.5M +30.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $178M +$50.7M +40% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $127M +$13M +11.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-16
2012 $114M -$4.42M -3.74% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $118M +$27.1M +29.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 $91.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.